Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...

At two years of follow-up, patients with a poorly functioning tricuspid valve in the heart who received the best available ...

Background Cardiac surgery carries a heightened risk of bradyarrhythmias, but current permanent pacemaker (PPM) implantation ...

The Society for Cardiovascular Angiography & Interventions (SCAI) has published a first-of-its-kind educational resource for interventional cardiologists and imaging specialists performing ...

Ben McCullough, 76, received an EVOQUE heart valve last fall. On Wednesday, he got to thank the makers face-to-face.

The chordae tendineae (CT), often referred to as the “heart strings,” are thin, tendinous structures that connect the heart ...

CMS has approved Medicare and Medicaid coverage for transcatheter tricuspid valve replacement procedures for the treatment of ...

Laplace Interventional, a US-based medical device company focusing on transcatheter valve technology, recently announced the ...

Laplace has raised $22m in a Series C financing round to support the completion of EFS of transcatheter tricuspid valve technology.

Development of minimally invasive procedures to address mitral and tricuspid disease has lagged progress in aortic valve treatment, where Edwards Lifesciences and Medtronic are the leaders in a market ...